Related Experiment Video
Updated: Nov 12, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2
Cai-Feng Yue1, Lai-Sheng Li2, Lu Ai2
1Department of Laboratory Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, 524045, PR China.
Abstract:
The transcription factor nuclear factor (erythroid-2)-related factor 2 (Nrf2) can principally serve a mode of protection for both the normal cells and cancer cells from cellular stress, and elevates cancer cell survival. microRNA-28 (miR-28) has been involved in the regulation of Nrf2 expression in breast epithelial cells. However, no comprehensive analysis has been conducted regarding the function of miR-28-5p regulating Nrf2 in gastric cancer (GC). In this study, we aimed to evaluate their interaction and biological roles in the migration and invasion of GC cells. The expression of Nrf2 in the cancer tissues harvested from 42 patients with GC was examined by an array of molecular techniques comprising of Immunohistochemical staining, RT-qPCR and Western blot analysis. Kaplan-Meier method was adopted for analysis of the correlation of Nrf2 with the prognosis of GC patients. Interaction between miR-28-5p and Nrf2 was determined using the bioinformatics analysis and dual luciferase reporter gene assay. Gain- and loss-of-function studies of miR-28-5p and Nrf2 were conducted to elucidate their effects on GC cell migration, invasion and metastasis, as well as expression pattern of several epithelial-mesenchymal transition (EMT)-related proteins. Results indicated that the expression pattern of Nrf2 was significantly upregulated in GC tissues and indicative of poor prognosis of GC patients. miR-28-5p was verified to target Nrf2 and downregulate its expression. GC cells with overexpression of miR-28-5p or Nrf2 knockdown exhibited a marked reduction in the migrated and invasive abilities, along with the N-cadherin expression yet an increase of E-cadherin expression. Furthermore, miR-28-5p exerted an inhibitory function on the metastatic and tumorigenicity of GC cells. In conclusion, miR-28-5p is a comprehensive tumor suppressor that inhibits GC cell migration and invasion through repressing the Nrf2 expression. Therefore, miR-28-5p may serve as a potential biomarker for the prognosis of GC and a novel therapeutic target in advanced GC.
Insights
MicroRNA-28-5p acts as a tumor suppressor in gastric cancer by inhibiting Nrf2 expression, reducing cell migration and invasion. This finding suggests miR-28-5p as a potential biomarker and therapeutic target for gastric cancer.
Area of Science:
- Molecular Oncology
- Cancer Biology
- Gene Regulation
Background:
- Nuclear factor (erythroid-2)-related factor 2 (Nrf2) promotes cancer cell survival and is upregulated in gastric cancer (GC).
- MicroRNA-28 (miR-28) regulates Nrf2 in breast cells, but its role in GC is uncharacterized.
Purpose of the Study:
- To investigate the interaction between miR-28-5p and Nrf2 in gastric cancer.
- To elucidate their roles in GC cell migration, invasion, and metastasis.
Main Methods:
- Analysis of Nrf2 expression in GC tissues (n=42) via immunohistochemistry, RT-qPCR, and Western blot.
- Bioinformatics analysis and dual luciferase reporter assay to confirm miR-28-5p targeting of Nrf2.
- Gain- and loss-of-function studies to assess effects on GC cell behavior and epithelial-mesenchymal transition (EMT) markers.
Main Results:
- Nrf2 was significantly upregulated in GC tissues, correlating with poor prognosis.
- miR-28-5p directly targets and downregulates Nrf2 expression.
- Overexpression of miR-28-5p or Nrf2 knockdown reduced GC cell migration, invasion, and N-cadherin expression while increasing E-cadherin.
- miR-28-5p inhibited GC cell metastasis and tumorigenicity.
Conclusions:
- miR-28-5p functions as a tumor suppressor in GC by inhibiting Nrf2.
- miR-28-5p represses GC cell migration and invasion, potentially via regulating EMT.
- miR-28-5p shows promise as a prognostic biomarker and therapeutic target for advanced GC.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

